Actos May Be Linked to Bladder Cancer – FDA Resources
As you may have read from our previous post, the popular diabetes medication Actos has been linked to a possible increased risk of bladder cancer. The FDA has been reviewing data about Actos for over a year, and has come to the conclusion that the risk is high enough to warrant a label change. Label …
Continue reading ‘Actos May Be Linked to Bladder Cancer – FDA Resources’ »